Neuromyelitis Optica Overview
Learn About Neuromyelitis Optica
Neuromyelitis optica is an autoimmune disorder that affects the nerves of the eyes and the central nervous system, which includes the brain and spinal cord. Autoimmune disorders occur when the immune system malfunctions and attacks the body's own tissues and organs. In neuromyelitis optica, the autoimmune attack causes inflammation of the nerves, and the resulting damage leads to the signs and symptoms of the condition.
No genes associated with neuromyelitis optica have been identified. However, a small percentage of people with this condition have a family member who is also affected, which indicates that there may be one or more genetic changes that increase susceptibility. It is thought that the inheritance of this condition is complex and that many environmental and genetic factors are involved in the development of the condition.
Neuromyelitis optica affects approximately 1 to 2 per 100,000 people worldwide. Women are affected by this condition more frequently than men.
Neuromyelitis optica is usually not inherited. Rarely, this condition is passed through generations in families, but the inheritance pattern is unknown.
University Of Virginia Physicians Group
Brian Weinshenker is a Neurologist in Charlottesville, Virginia. Dr. Weinshenker and is rated as an Elite provider by MediFind in the treatment of Neuromyelitis Optica. His top areas of expertise are Transverse Myelitis, Neuromyelitis Optica, Optic Neuritis, and Multiple Sclerosis (MS). Dr. Weinshenker is currently accepting new patients.
Kazuo Fujihara practices in Fukushima, Japan. Fujihara and is rated as an Elite expert by MediFind in the treatment of Neuromyelitis Optica. His top areas of expertise are Neuromyelitis Optica, Transverse Myelitis, Optic Neuritis, Myelitis, and Thymectomy.
Romain Marignier practices in Lyon, France. Marignier and is rated as an Elite expert by MediFind in the treatment of Neuromyelitis Optica. His top areas of expertise are Optic Neuritis, Transverse Myelitis, Neuromyelitis Optica, and Multiple Sclerosis (MS).
Summary: This project aims to study whether a structured wellness program intervention can improve quality of life among people living with Neuromyelitis Optica Spectrum Disorder (NMOSD). This pilot will test a multi-modal wellness program tailored to NMOSD patients that includes services from physical therapists, dietitians, social workers, nurse practitioners and cognitive therapists. The trial will be d...
Summary: The primary purpose of this study is to evaluate the safety and efficacy of ravulizumab in pediatric participants with Neuromyelitis Optica Spectrum Disorder (NMOSD).
Published Date: March 01, 2015
Published By: National Institutes of Health